Timsit, Jean-François http://orcid.org/0000-0002-6063-7383
Ruppé, Etienne
Barbier, François
Tabah, Alexis
Bassetti, Matteo
Article History
Received: 14 October 2019
Accepted: 23 January 2020
First Online: 11 February 2020
Compliance with ethical standards
:
: The authors declare no conflict of interest linked to the submitted work. Outside the submitted work: JFT declares research grants from Pfizer, Merck, 3 M, Astellas, Biomerieux; scientific Board participation with Maat Pharma, Merck, Bayer pharma, Medimune, Gilead, VenatoRx, Nabriva, Paratek; lecture fees for Merck, Pfizer, Biomerieux.ER declares research grants from bioMérieux; scientific board participation with MaaT Pharma, Pathoquest, DaVolterra and Illumina; lecture fees from MSD, Pfizer, Mobidiag and Correvio.FB declares lectures fees from Merck and BioMérieux, scientific board participation with Merck, and conference invitation from Pfizer and Merck. MB has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, Bayer, Basilea, Biomerieux, Cidara, Gilead, Menarini, MSD, Nabriva, Paratek, Pfizer, Roche, Melinta, Shionogi, Tetraphase, VenatoRx and Vifor and has received study grants from Angelini, Basilea, Astellas, Shionogi, Cidara, Melinta, Gilead, Pfizer and MSD.
Free to read: This content has been made available to all.